Covering Neonatal Abstinence Syndrome Reports: A Practical Guide for Local News Teams
I spent about four years working health beat at a mid-market station, and NAS stories are some of the most technically complicated reports you will ever have to produce. They sit somewhere between public health documentation and human interest, and if you get the details wrong your fact-checker will tear the piece apart on air. Most producers treat it like a straightforward sick-baby story. It is not. The core of any NAS investigation starts with understanding what actually qualifies as Neonatal Abstinence Syndrome versus the broader category of congenital opioid exposure. They are not interchangeable. NAS specifically refers to the withdrawal syndrome that develops after a newborn is exposed to opioids in utero and then experiences physiological withdrawal post-birth. A baby can have intrauterine opioid exposure without meeting the diagnostic criteria for NAS. Getting this distinction right in your script matters because maternal health researchers and pediatric neonatologists will immediately flag the difference. When my team covered this story locally, we had a pediatrician on staff who quietly corrected three separate drafts. The issue was subtle but important: we had been using "opioid addiction" when the clinical literature preferred "opioid use disorder." It sounds like semantics, but the distinction carries real weight in how readers interpret the story and whether your medical guests will sit for an interview willing to go on record.
Here is how to actually structure the investigation side of this. Start with the data layer before you touch any camera. The CDC publishes state-level hospital discharge data on NAS rates every year. Most local stations ignore this source and instead lead with anecdotes, which makes for emotional television but a thin story. Find your state's specific NAS incidence rate per 1,000 hospital stays. Compare it to the national average. If your market's rate is significantly elevated, that is your news hook. Without that baseline, you are just telling sad stories without a story behind them. The frontline investigator work involves several moving parts. You need a pediatric neonatologist who can explain the scoring systems used to diagnose NAS. The Finnegan scale is the standard tool most NICUs use. It assigns point values across multiple categories: CNS irritability, gastrointestinal function, respiratory status, and autonomic signs. A score above a certain threshold triggers treatment protocols. Most parents have no idea their newborn was assessed using a numbered scoring system. Explaining this clearly to viewers without turning it into a textbook lecture is genuinely difficult. I learned this the hard way during a live shot where our reporter tried to walk through the Finnegan scoring process in under thirty seconds. It collapsed. The audience got confused, the medical guest looked frustrated, and the segment ran over. The fix was to pre-produce a simple on-screen graphic showing the four assessment categories with one plain-language example for each. We kept the audio to a single sentence per category. The graphic did the heavy lifting. That approach increased our call-in line volume by roughly three times the next week because parents actually understood what they were hearing about.
Another counter-intuitive thing about NAS reporting: the mother is not always the easiest subject to interview. Women with opioid use disorder face substantial stigma even in compassionate media environments, and many will decline an on-camera interview outright. When I pushed too hard for a maternal interview, I lost two guests in a single week. The workaround was to interview neonatal nurse practitioners who specialize in NAS care. They see the full spectrum of cases daily and can speak to both clinical outcomes and the systemic gaps in treatment access. Their interviews tended to be more substantive because they were describing patterns rather than personal trauma. The investigation angle should also look at treatment availability. NAS treatment protocols vary dramatically between hospitals in the same state. Some facilities use morphine weaning as first-line treatment. Others prefer buprenorphine. A few have moved to non-pharmacological approaches using swaddling, rooming-in, and reduced environmental stimulation as the primary intervention. These differences are rarely documented in any public database. Finding them requires calling individual hospital neonatal units and asking to speak with a charge nurse or a pharmacy director. It is tedious work, but the variation itself is newsworthy and most local stations do not do it. There is a specific edge case I ran into that I want to document here. We discovered through our investigation that one regional hospital had stopped using the Finnegan scale entirely and replaced it with a modified version that weighted respiratory symptoms more heavily. This meant babies at that facility were being flagged for pharmacological treatment at lower symptom thresholds than comparable infants at neighboring hospitals. The difference was not captured in any public report. When we tried to verify this, the hospital's public relations office initially pushed back, saying the change was purely administrative. I ended up getting a retired NICU nurse from that facility to confirm the operational difference on background. She described the change as creating what she called "diagnostic inflation," where more babies met treatment criteria without actually showing worse clinical outcomes. We ran with that story. It generated more feedback than anything else we produced that quarter.
Get the Full Details
Common pitfalls to avoid. Do not conflate methadone maintenance treatment with illicit opioid use. They are clinically distinct, and your medical guests will correct you if you blur the lines. Do not imply that NAS is caused solely by opioids; other substances including benzodiazepines, SSRIs, and barbiturates can produce similar withdrawal presentations. Do not use language that frames the babies as victims of parental negligence without first establishing that opioid use disorder is a recognized medical condition, not a moral failing. The mothers you are covering are patients, and your language should reflect that. Resources worth tracking include the Maternal Health and Opioid Use Research Network, the American Academy of Pediatrics clinical practice guidelines on NAS published in 2022, and your state's perinatal quality collaborative if one exists. These sources provide the data backbone that separates a responsible investigation from exploitation dressed up as concern. The biggest limitation of NAS reporting as a genre is the turnaround time. By the time you gather enough data to tell a statistically informed story, the breaking-news window has usually closed. The condition does not produce viral headlines on its own. The payoff is longer-form audience trust. Viewers who see consistent, accurate coverage of NAS over multiple news cycles tend to return for follow-up pieces and engage more deeply with related public health content. Short-term ratings impact is minimal. Long-term credibility impact is significant.
If your station does not have an existing relationship with a neonatologist or a pediatric pharmacist, start building one before you need it. These conversations take time to develop, and trying to cold-call a NICU attending during an active news cycle rarely produces useful results. A sixty-second on-camera explanation of NAS that is medically accurate is worth more than ten dramatic segments that get corrected in print the next morning.
